Preferred Label : GBM Antigens and Alloantigens Immunotherapeutic Vaccine;
NCIt definition : An orally bioavailable, immunotherapeutic vaccine composed of hydrolyzed and formulated
glioblastoma multiforme (GBM) antigens and alloantigens derived from a pool of patients'
cancer cells in the blood and samples of tumor tissues, with potential immunomodulating
and antineoplastic activities. Upon oral administration of the GBM antigens and alloantigens
immunotherapeutic vaccine, the GBM antigens and alloantigens may stimulate the host
immune system via antigen-presenting cells (APCs) lining the gut to mount an immune
response against tumor cells expressing these antigens. This may lead to tumor cell
death.;
Drug name : V-Boost; V-Boost Immunitor;
NCI Metathesaurus CUI : CL1406091;
Origin ID : C172199;
UMLS CUI : C5419510;
- Semantic type(s)
- concept_is_in_subset